Jubilant Revenues Flat In Q2 On LSI Business Decline, FDA action

LSI To Be Demerged, Founder Cos Merged In Restructuring

 
• By Vibha Ravi
  
Teamwork
Business Restructuring At Jubilant Aims At Improving Focus On Different Segments
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip